Loading...
Temozolomide — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Temozolomide
2025-Q4
Comprehensive analysis of India’s temozolomide export trade — suppliers, buyers, prices, routes, and every shipment record.
124
Shipments
$1.81M
Trade Value
40
Suppliers
39
Buyers
38
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/temozolomide
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s temozolomide trade — 2025-Q4
KEY TAKEAWAY
Temozolomide 2025-Q4 exports total $1.8M across 38 countries, with SUN PHARMACEUTICAL INDUSTRIES LTD commanding 89.9% market share.
TOTAL SHIPMENTS
124
2025-Q4
EXPORT VALUE
$1.8M
FOB USD
TOTAL QUANTITY
336.9K
units shipped
INDIAN SUPPLIERS
40
unique exporters
GLOBAL BUYERS
39
unique importers
DESTINATIONS
38
countries
MEDIAN UNIT PRICE
$4.54
per unit
TOP-5 SHARE
98.2%
of total USD
BRANDED SHARE
58.9%
73 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
SUN PHARMACEUTICAL INDUSTRIES LTD is India's #1 Temozolomide exporter with $1.6M (89.9% market share).→ §5, Indian Supplier Rankings
2
Temozolomide reached 38 countries, with Colombia as the top destination ($778.7K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 8116) — top 10 suppliers control 99.3% of exports.→ §5, Indian Supplier Rankings
4
94.9% of buyers (37 of 39) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Capsule dominates (98.2%) across 3 dosage forms.→ §7, Price Benchmarks
6
38 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 SUN PHARMACEUTICAL INDUSTRIES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian temozolomide exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Temozolomide report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial temozolomide trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian temozolomide suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Temozolomide India trade report
Product scope
Temozolomide
All variants merged — branded and generic formulations of temozolomide
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
124
Every commercial temozolomide trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $397.9K, Nov $1.3M, Dec $115.6K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$397.9K
Oct USD
12 shipments
2
$1.3M
Nov USD
+226.5% MoM
3
$115.6K
Dec USD
-91.1% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 226.5% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $398K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.8M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $901K rise in Nov, $1.2M decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $398K | 12 shipments |
| Nov | $1.3M | 51 shipments |
| Dec | $116K | 61 shipments |
| Q4 Total | $1.8M | 124 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Belgium held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: SUN PHARMACEUTICAL INDUSTRIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import temozolomide from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Colombia absorbs 43.0% of India’s 2025-Q4 temozolomide trade ($778.7K). Beyond the top 10 destinations, 38 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 38 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much temozolomide India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$112K
6.2% of trade
16 countries · 48 shipments
Europe
$341K
18.8% of trade
5 countries · 24 shipments
Americas
$1.4M
74.6% of trade
8 countries · 24 shipments
Africa
$7K
0.4% of trade
9 countries · 28 shipments
Fig 4.1 Colombia is the #1 corridor ($779K) — 30 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian temozolomide it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Colombia | $779K | 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | $779K | — | — | — | — |
| 2 | Brazil | $324K | 6 | SUN PHARMACEUTICAL INDUSTRIES LTD | $324K | — | — | — | — |
| 3 | Belgium | $298K | 15 | SUN PHARMACEUTICAL INDUSTRIES LTD | $298K | — | — | — | — |
| 4 | Canada | $229K | 4 | SUN PHARMACEUTICAL INDUSTRIES LTD | $229K | RELIANCE LIFE SCIENCES PVT LTD | $383 | — | — |
| 5 | Vietnam | $54K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $54K | RV LIFESCIENCES LTD | $405 | — | — |
| 6 | Hungary | $42K | 4 | JODAS EXPOIM PVT LTD | $42K | — | — | — | — |
| 7 | Malaysia | $21K | 2 | RELIANCE LIFE SCIENCES PVT LTD | $21K | — | — | — | — |
| 8 | Lebanon | $15K | 7 | GLOBELA PHARMA PVT LTD | $13K | RMPL PHARMA LLP | $2K | — | — |
| 9 | Paraguay | $11K | 1 | RELIANCE LIFE SCIENCES PVT LTD | $11K | — | — | — | — |
| 10 | Kazakhstan | $9K | 3 | INNOMEDIX PHARMA PVT LTD | $5K | AVALOR HEALTH CARE PVT LTD | $4K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 6.2% of USD — but Colombia is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
43.0%
#1 country share
Colombia alone
92.9%
Top 5 share
5 of 38 countries
99.3%
Top 15 share
Long tail of 23 countries = 0.7%
HHI 2613
Destination HHI
Highly concentrated
38
Countries served
Global pharma reach from India
16
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
40 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
SUN PHARMACEUTICAL INDUSTRIES LTD ($1.6M, 89.9% share) and RELIANCE LIFE SCIENCES PVT LTD ($89.8K) together control 94.9% of India’s 2025-Q4 temozolomide trade. The top 5 suppliers hold 98.2%. 40 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian temozolomide suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 SUN PHARMACEUTICAL INDUSTRIES LTD leads by $1.5M over RELIANCE LIFE SCIENCES PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: GLOBELA PHARMA PVT is #4 by value but #13 by volume.
Fig 5.2 SUN PHARMACEUTICAL INDUSTRIES LTD also leads by shipment count (25) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: GLOBELA PHARMA PVT moves from #13 by volume to #4 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 40 temozolomide suppliers split into strategic segments
KEY TAKEAWAY
10 suppliers (25%) generate 99.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 SUN PHARMACEUTICAL INDUSTRIES LTD and RELIANCE LIFE SCIENCES PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.3% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PVT LTD | 2 | 6 | $90K |
| 2 | VANDAN HEALTHCARE | 2 | 1 | $465 |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD | 1 | 4 | $1.6M |
| 4 | JODAS EXPOIM PVT LTD | 1 | 1 | $42K |
| 5 | GLOBELA PHARMA PVT LTD | 1 | 1 | $13K |
| 6 | CSP LIFESCIENCES PVT LTD | 1 | 1 | $5K |
| 7 | KWALITY PHARMACEUTICALS LTD | 1 | 1 | $5K |
| 8 | INNOMEDIX PHARMA PVT LTD | 1 | 1 | $5K |
| 9 | AVALOR HEALTH CARE PVT LTD | 1 | 1 | $4K |
| 10 | VITALITYMED | 1 | 1 | $4K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the temozolomide manufacturing hubs
KEY TAKEAWAY
Mumbai and Andheri Kurla Road together account for $1.6M of India’s 2025-Q4 temozolomide trade.
Fig 5.5 Mumbai (9 exporters, $1.2M) and Andheri Kurla Road (1 exporters, $436K) are India’s temozolomide capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
98.2%
Top 5 share
5 of 40 suppliers
99.3%
Top 10 share
10 of 40 suppliers
99.3%
Top 25% share
10 suppliers = 99% USD
HHI 8116
Supplier HHI
Concentrated
40
Total suppliers
shipped Temozolomide in 2025-Q4
20+ cities
Indian hubs
Mumbai and Andheri Kurla Road lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | SUN PHARMACEUTICAL INDUSTRIES LTD | $1.6M |
| #2 | RELIANCE LIFE SCIENCES PVT LTD | $90K |
| #3 | RMPL PHARMA LLP | $2K |
| #4 | HEET HEALTHCARE PVT LTD | $2K |
#1
EXPORTER PROFILE #1 OF 4
SUN PHARMACEUTICAL INDUSTRIES LTD
Mumbai · India’s #1 temozolomide supplier by USD · 2025-Q4
2025-Q4 USD
$1.6M
89.9% market share
SHIPMENTS
25
avg $65K/ship
COUNTRIES
4
destination markets
BUYERS
6
5 single-sourced
BRANDED
64%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Colombia is the #1 market at $779K (48% of trade), followed by Brazil at $324K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Colombia | $779K | 2 | 47.8% |
| 2 | Brazil | $324K | 6 | 19.9% |
| 3 | Belgium | $298K | 15 | 18.3% |
| 4 | Canada | $229K | 2 | 14.1% |
MONTHLY TREND
Nov peaked at $1.2M. Dec was the weakest at $33K.
PRODUCT MIX
Capsule dominates at 100% of trade.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Brazil | $436K | N/A |
| LABORATORIOS LA SANTE … | Colombia | $389K | ⚠ Locked |
| SUN FARMACEUTICA DO BR… | Brazil | $277K | ⚠ Locked |
| M/S.SUN PHARMA CANADA … | Canada | $229K | ⚠ Locked |
| YUSEN LOGISTICS BENELU… | Belgium | $168K | ⚠ Locked |
| YUSEN LOGISTICS BENELU… | Belgium | $131K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
SUN PHARMACEUTICAL INDUSTRIES LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P1.3 Colombia absorbs $779K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#2
EXPORTER PROFILE #2 OF 4
RELIANCE LIFE SCIENCES PVT LTD
Navi Mumbai Maharashtra · India’s #2 temozolomide supplier by USD · 2025-Q4
2025-Q4 USD
$90K
5.0% market share
SHIPMENTS
11
avg $8K/ship
COUNTRIES
6
destination markets
BUYERS
7
6 single-sourced
BRANDED
91%
of shipments
DOSAGE FORMS
2
product types
TOP 6 DESTINATIONS
Vietnam is the #1 market at $54K (60% of trade), followed by Malaysia at $21K. 6 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Vietnam | $54K | 1 | 59.8% |
| 2 | Malaysia | $21K | 2 | 22.9% |
| 3 | Paraguay | $11K | 1 | 12.1% |
| 4 | Singapore | $2K | 2 | 2.6% |
| 5 | Nepal | $2K | 3 | 2.2% |
| 6 | Canada | $383 | 2 | 0.4% |
MONTHLY TREND
Nov peaked at $77K. Oct was the weakest at $790.
PRODUCT MIX
Capsule dominates at 86% of trade. Tablet (13.9%) and others are secondary formulations.
TOP BUYERS · 6/6 LOCKED IN
6 of 6 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| DELTA IMPORT - EXPORT … | Vietnam | $54K | ⚠ Locked |
| Undisclosed buyer | Singapore | $11K | N/A |
| BIOTENG S.A | Paraguay | $11K | ⚠ Locked |
| SCHMIDT BIOMEDTECH SDN… | Malaysia | $10K | ⚠ Locked |
| PHARMACHEM PVT LTD | Nepal | $2K | ⚠ Locked |
| WELLCHEM PHARMACEUTICA… | Singapore | $1K | ⚠ Locked |
| JAMP PHARMA CORP | Canada | $383 | ⚠ Locked |
#2
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
RELIANCE LIFE SCIENCES PVT LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 Vietnam absorbs $54K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#12
EXPORTER PROFILE #3 OF 4
RMPL PHARMA LLP
Mumbai · India’s #12 temozolomide supplier by USD · 2025-Q4
2025-Q4 USD
$2K
0.1% market share
SHIPMENTS
7
avg $240/ship
COUNTRIES
2
destination markets
BUYERS
1
unique importers
BRANDED
57%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Lebanon is the #1 market at $2K (100% of trade), followed by Turkey at $3. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Lebanon | $2K | 6 | 99.8% |
| 2 | Turkey | $3 | 1 | 0.2% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $2K.
PRODUCT MIX
Capsule dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Lebanon | $2K | N/A |
#12
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
RMPL PHARMA LLP — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Lebanon absorbs $2K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#13
EXPORTER PROFILE #4 OF 4
HEET HEALTHCARE PVT LTD
Ahmedabad · India’s #13 temozolomide supplier by USD · 2025-Q4
2025-Q4 USD
$2K
0.1% market share
SHIPMENTS
7
avg $238/ship
COUNTRIES
2
destination markets
BUYERS
2
unique importers
BRANDED
0%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Zimbabwe is the #1 market at $1K (64% of trade), followed by Poland at $599. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Zimbabwe | $1K | 4 | 64.0% |
| 2 | Poland | $599 | 3 | 36.0% |
MONTHLY TREND
Nov peaked at $1K. Dec was the weakest at $0.
PRODUCT MIX
Capsule dominates at 64% of trade. Unknown (36.0%) and others are secondary formulations.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Zimbabwe | $1K | N/A |
| Undisclosed buyer | Zimbabwe | $339 | N/A |
#13
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
HEET HEALTHCARE PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P4.3 Zimbabwe absorbs $1K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
39 importers across 38 countries — who is buying Indian temozolomide and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 73.7% of total USD. 95% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian temozolomide. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 LABORATORIOS LA SANTE S.A is the #1 importer at $389K (21.5%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
95%
Single-source
37 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
5%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source temozolomide from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Afghanistan 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TRUST ANESTHETIC LTD | KWALITY PHARMACEUTIC… | $5K | $0.084 | Capsule |
| MUBARAK HASHIMI LTD | KERK | $245.457 | $1.364 | Capsule |
| SARTAJ ENTERPRISES LTD | SARTAJ PHARMA PVT LTD | $26.096 | $0.022 | Capsule |
United Arab Emirates 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ANSYNC GLOBAL FZCO | OCEAN PHARMACEUTICAL | $518.670 | $5.460 | Capsule |
| ZMC EXPRESS CARGO FZCO | SEATRACK INTERNATION… | $84.990 | $4.249 | Capsule |
| EMIRATES POST COMPANY | IASO PHARMACEUTICALS… | $55.047 | $9.174 | Capsule |
Iraq 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ASBAR ALMOSTQBAL | RELICURE HEALTHCARE | $177.677 | $4.442 | Capsule |
| ATLAS TRADING COMPANY | VATS INDUSTRIES PVT … | $91.014 | $4.551 | — |
| ZHARAWA LTD | RELICURE HEALTHCARE | $1.995 | $0.050 | Capsule |
Canada 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| M/S.SUN PHARMA CANADA … | SUN PHARMACEUTICAL I… | $229K | $93.540 | Capsule |
| JAMP PHARMA CORP | RELIANCE LIFE SCIENC… | $382.688 | $0.096 | Tablet |
Belgium 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| YUSEN LOGISTICS BENELU… | SUN PHARMACEUTICAL I… | $168K | $7.102 | Capsule |
| YUSEN LOGISTICS BENELU… | SUN PHARMACEUTICAL I… | $131K | $2.792 | Capsule |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | LABORATORIOS LA SANT… | Colombia | $389K | $389K | Premium |
| 2 | SUN FARMACEUTICA DO … | Brazil | $277K | $55K | Premium |
| 3 | M/S.SUN PHARMA CANAD… | Canada | $229K | $115K | Premium |
| 4 | YUSEN LOGISTICS BENE… | Belgium | $168K | $24K | Mid |
| 5 | YUSEN LOGISTICS BENE… | Belgium | $131K | $16K | Mid |
| 6 | DELTA IMPORT - EXPOR… | Vietnam | $54K | $54K | Premium |
| 7 | PHARMACENTER HUNGARY… | Hungary | $42K | $10K | Budget |
| 8 | BIOTENG S.A | Paraguay | $11K | $11K | Budget |
| 9 | SCHMIDT BIOMEDTECH S… | Malaysia | $10K | $10K | Budget |
| 10 | TRUST ANESTHETIC LTD | Afghanistan | $5K | $5K | Budget |
| 11 | KAZBIOTECH LLP | Kazakhstan | $5K | $2K | Budget |
| 12 | TOO AVCARE LTD | Kazakhstan | $4K | $4K | Budget |
| 13 | FARMADONIC LTD | Chile | $4K | $2K | Budget |
| 14 | PHARMACHEM PVT LTD | Nepal | $2K | $660.000 | Budget |
| 15 | FREIGHTER MADE LOGIS… | Ghana | $1K | $418.000 | Budget |
| 16 | WELLCHEM PHARMACEUTI… | Singapore | $1K | $1K | Budget |
| 17 | ANSYNC GLOBAL FZCO | United Arab Emirates | $518.670 | $519.000 | Budget |
| 18 | DELTA IMPORT-EXPORT … | Vietnam | $405.374 | $405.000 | Budget |
| 19 | JAMP PHARMA CORP | Canada | $382.688 | $191.000 | Budget |
| 20 | MR VONMUNA | Laos | $371.177 | $371.000 | Budget |
| 21 | RADEEP SERVICES | Singapore | $340.847 | $341.000 | Budget |
| 22 | TO THE PURCHASE DEPT | United Kingdom | $268.199 | $268.000 | Budget |
| 23 | MUBARAK HASHIMI LTD | Afghanistan | $245.457 | $245.000 | Budget |
| 24 | ABU AHMED | Kenya | $237.056 | $119.000 | Budget |
| 25 | ASBAR ALMOSTQBAL | Iraq | $177.677 | $178.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 SUN PHARMACEUTICAL INDUSTRIES LTD → LABORATORIOS LA SANTE S.A is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian temozolomide prices vary by supplier, country and dosage form
KEY TAKEAWAY
Temozolomide prices span 78617× ($0.022 → $1755.00). The coefficient of variation is 5.85. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.022 | Lowest observed unit price |
| P5 | $0.045 | 5th percentile |
| P25 | $2.17 | 25th percentile (Q1) |
| Median | $4.54 | 50th percentile (Q2) |
| P75 | $9.64 | 75th percentile (Q3) |
| P95 | $42.43 | 95th percentile |
| Max | $1.8K | Highest observed unit price |
| Mean | $38.12 | Arithmetic average |
| CV | 585% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 VITALITYMED prices at $2K/unit vs market median $4.54.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. JODAS EXPOIM PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SUN PHARMACEUTICAL INDUSTRIES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. CSP LIFESCIENCES PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. GLOBELA PHARMA PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | VITALITYMED | Chile | Tablet | 1 | $2K | $2K | Specialty / small-batch |
| Nov 2025 | VITALITYMED | Chile | Tablet | 1 | $2K | $2K | Specialty / small-batch |
| Oct 2025 | SUN PHARMACEUTIC… | Canada | Capsule | 1K | $152K | $143.62 | Specialty / small-batch |
| Oct 2025 | SUN PHARMACEUTIC… | Belgium | Capsule | 977 | $55K | $56.63 | Specialty / small-batch |
| Oct 2025 | SUN PHARMACEUTIC… | Canada | Capsule | 1K | $77K | $55.58 | Specialty / small-batch |
| Nov 2025 | SUN PHARMACEUTIC… | Colombia | Capsule | 9K | $389K | $42.43 | Specialty / small-batch |
| Nov 2025 | SUN PHARMACEUTIC… | Colombia | Capsule | 9K | $389K | $42.43 | Specialty / small-batch |
| Nov 2025 | SUN PHARMACEUTIC… | Brazil | Capsule | 1K | $45K | $37.86 | Specialty / small-batch |
| Oct 2025 | HEET HEALTHCARE … | Zimbabwe | Capsule | 5 | $185.42 | $37.08 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Zimbabwe | Capsule | 10 | $339.42 | $33.94 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | SUN PHARMACEUTIC… | Belgium | Capsule | 1K | $16.22 | $0.012 | |
| Dec 2025 | SARTAJ PHARMA PV… | Afghanistan | Capsule | 1K | $26.10 | $0.022 | |
| Dec 2025 | RELIANCE LIFE SC… | Canada | Tablet | 2K | $66.06 | $0.033 | |
| Dec 2025 | SEVATTO PHARMACE… | Mauritius | Capsule | 6K | $205.08 | $0.036 | |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Capsule | 500 | $18.85 | $0.038 | Small sample / trial shipment |
| Dec 2025 | RMPL PHARMA LLP | Lebanon | Capsule | 2 | $0.090 | $0.045 | Small sample / trial shipment |
| Dec 2025 | RMPL PHARMA LLP | Lebanon | Capsule | 16 | $0.719 | $0.045 | Small sample / trial shipment |
| Dec 2025 | RMPL PHARMA LLP | Lebanon | Capsule | 12 | $0.540 | $0.045 | Small sample / trial shipment |
| Dec 2025 | RMPL PHARMA LLP | Turkey | Capsule | 60 | $2.76 | $0.046 | Small sample / trial shipment |
| Dec 2025 | RELICURE HEALTHC… | Iraq | Capsule | 40 | $2.00 | $0.050 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship temozolomide, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Temozolomide leaves India through 10+ ports. The top 5 (MUMBAI AIR (SAHAR), DELHI AIR, NHAVA SHEVA SEA (JNPT)) handle 99.8% of total USD. AIR moves 79% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $934K — top 10 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 BOGOTA is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 79% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$1.3M
71.2% of USD · 79.0% of ships
SEA
$291K
16.0% of USD · 13.7% of ships
ICD
$230K
12.7% of USD · 4.8% of ships
ROAD
$2K
0.1% of USD · 2.4% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → LatAm ($793K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Belgium is the most concentrated destination (HHI 10000, 1 suppliers). Kazakhstan is the most competitive (HHI 5087).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Belgium (HHI 10,000) is the most concentrated — Kazakhstan (HHI 5,087) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| LABORATORIOS LA SANT… | Colombia | SUN PHARMACEUTIC… | $389K | 1 | HIGH |
| SUN FARMACEUTICA DO … | Brazil | SUN PHARMACEUTIC… | $277K | 5 | HIGH |
| M/S.SUN PHARMA CANAD… | Canada | SUN PHARMACEUTIC… | $229K | 2 | HIGH |
| YUSEN LOGISTICS BENE… | Belgium | SUN PHARMACEUTIC… | $168K | 7 | HIGH |
| YUSEN LOGISTICS BENE… | Belgium | SUN PHARMACEUTIC… | $131K | 8 | HIGH |
| DELTA IMPORT - EXPOR… | Vietnam | RELIANCE LIFE SC… | $54K | 1 | MEDIUM |
| PHARMACENTER HUNGARY… | Hungary | JODAS EXPOIM PVT… | $42K | 4 | MEDIUM |
| BIOTENG S.A | Paraguay | RELIANCE LIFE SC… | $11K | 1 | MEDIUM |
Conclusion: 37 buyers depend on exactly one Indian supplier, representing $1.3M in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Belgium | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Canada | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Vietnam | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Hungary | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Malaysia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Paraguay | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kazakhstan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Colombia | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Belgium lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Colombia (1 suppliers) | This Q | HIGH |
| A6 | Enter Brazil (1 suppliers) | This Q | MED |
| A8 | Build Brazil distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Colombia tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Colombia | Other | 1 | $779K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Brazil | Other | 1 | $324K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Belgium | Other | 1 | $298K | -80.2% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Canada | Other | 2 | $229K | -99.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Vietnam | Asia | 2 | $54K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Hungary | Other | 1 | $42K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Malaysia | Asia | 1 | $21K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Lebanon | Other | 2 | $15K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Paraguay | Other | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Kazakhstan | Asia | 2 | $9K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Afghanistan | Asia | 3 | $5K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 12 | Peru | Other | 1 | $5K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Nepal | Asia | 2 | $2K | +71.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Chile | Other | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Singapore | Asia | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 124 2025-Q4 Temozolomide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/temozolomide
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 124 2025-Q4 temozolomide shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian temozolomide shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
124
across all regions
TOTAL USD
$1.81M
2025-Q4 FOB value
UNITS
336.9K
tablets, capsules, etc.
SUPPLIERS
40
Indian exporters
BUYERS
39
global importers
COUNTRIES
38
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $7K (0.4%), spanning 9 countries.
40 Indian suppliers shipped to 39 buyers across 38 countries — average shipment value $15K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
9 countries · 28 shipments · $7K · 10 Indian suppliers · 5 buyers
SHIPMENTS
28
USD
$7K
COUNTRIES
9
SUPPLIERS
10
BUYERS
5
HHI
2,224
moderate
Top 9 destination countries in Africa
1
Ghana (34.5%)
$3K
2
Kenya (27.7%)
$2K
3
Zimbabwe (14.7%)
$1K
4
Eritrea (13.5%)
$979.68
5
Burkina Faso (3.8%)
$277.70
6
Mauritius (2.8%)
$205.08
7
Cameroon (2.7%)
$199.00
8
Egypt (0.3%)
$20.70
9
Cote d'Ivoire (0.0%)
$0.382
Top 10 Indian suppliers into Africa
1
BAKER & DAVIS PVT LTD
$3K
2
R.S. SURGIPHARM PVT LTD
$2K
3
HEET HEALTHCARE PVT LTD
$1K
4
MATU INTERNATIONAL PVT LTD
$979.68
5
SANSKRUTI PHARMA
$277.70
6
AMARI TRADE ALLIANCE LLP
$237.06
7
SEVATTO PHARMACEUTICALS PVT LTD
$205.08
8
KLV HEALTHCARE PVT LTD
$199.00
9
J.A. UNITED EXPORTS PVT LTD
$20.70
10
BRUCK PHARMA PVT LTD
$0.382
Top 3 Africa importers
1
FREIGHTER MADE LOGISTICS LTD · Ghana
$1K
2
ABU AHMED · Kenya
$237.06
3
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$20.70
Top 2 dosage forms
1
Capsule
$7K
2
Tablet
$277.70
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $385.88 | $192.94 |
| Nov | 13 | $4K | $284.56 |
| Dec | 13 | $3K | $244.59 |
Shipment register · 28 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BAKER & DAVIS PVT LTD · 6 shipments · $3K | |||||||||||
| 1 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Capsule | 20 | NOS | $4.54 | $90.84 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 2 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Capsule | 80 | NOS | $4.54 | $363.38 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 3 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Capsule | 100 | NOS | $7.99 | $798.64 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Ghana | Capsule | 20 | NOS | $4.54 | $90.84 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Ghana | Capsule | 80 | NOS | $4.54 | $363.38 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Ghana | Capsule | 100 | NOS | $7.99 | $798.64 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #2 — R.S. SURGIPHARM PVT LTD · 5 shipments · $2K | |||||||||||
| 7 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 20 | NOS | $1.52 | $30.32 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 8 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 10 | NOS | $9.64 | $96.39 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 9 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 100 | PCS | $10.56 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 10 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 100 | PCS | $4.36 | $436.30 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 11 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 10 | PCS | $15.55 | $155.55 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #3 — HEET HEALTHCARE PVT LTD · 4 shipments · $1K | |||||||||||
| 12 | Oct 2025 | UNLISTED BUYER | Zimbabwe | Capsule | 10 | PCS | $20.05 | $200.46 | AHMEDABAD AIR | HARARE | AIR |
| 13 | Oct 2025 | UNLISTED BUYER | Zimbabwe | Capsule | 5 | PCS | $37.08 | $185.42 | AHMEDABAD AIR | HARARE | AIR |
| 14 | Nov 2025 | UNLISTED BUYER | Zimbabwe | Capsule | 10 | NOS | $33.94 | $339.42 | AHMEDABAD AIR | HARARE | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | Zimbabwe | Capsule | 10 | NOS | $33.94 | $339.42 | AHMEDABAD AIR | HARARE | AIR |
| SUPPLIER #4 — MATU INTERNATIONAL PVT LTD · 2 shipments · $979.68 | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | Eritrea | Capsule | 100 | NOS | $3.67 | $367.38 | PATLI ICD | MASSAWA | ICD |
| 17 | Dec 2025 | UNLISTED BUYER | Eritrea | Capsule | 100 | NOS | $6.12 | $612.30 | PATLI ICD | MASSAWA | ICD |
| SUPPLIER #5 — SANSKRUTI PHARMA · 3 shipments · $277.70 | |||||||||||
| 18 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 12 | NOS | $7.92 | $95.00 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 19 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 12 | NOS | $7.61 | $91.35 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 20 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Tablet | 12 | NOS | $7.61 | $91.35 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #6 — AMARI TRADE ALLIANCE LLP · 2 shipments · $237.06 | |||||||||||
| 21 | Nov 2025 | ABU AHMED | Kenya | Capsule | 50 | NOS | $3.82 | $191.17 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 22 | Nov 2025 | ABU AHMED | Kenya | Capsule | 20 | NOS | $2.29 | $45.88 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #7 — SEVATTO PHARMACEUTICALS PVT LTD · 1 shipments · $205.08 | |||||||||||
| 23 | Dec 2025 | UNLISTED BUYER | Mauritius | Capsule | 5.6K | NOS | $0.036 | $205.08 | MUNDRA SEA | Port Louis | SEA |
| SUPPLIER #8 — KLV HEALTHCARE PVT LTD · 1 shipments · $199.00 | |||||||||||
| 24 | Dec 2025 | UNLISTED BUYER | Cameroon | Capsule | 30 | NOS | $6.63 | $199.00 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #9 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $20.70 | |||||||||||
| 25 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Capsule | 60 | NOS | $0.055 | $3.31 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| 26 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Capsule | 117 | NOS | $0.149 | $17.39 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| SUPPLIER #10 — BRUCK PHARMA PVT LTD · 2 shipments · $0.382 | |||||||||||
| 27 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Capsule | 1 | NOS | $0.059 | $0.059 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Capsule | 3 | NOS | $0.108 | $0.323 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
16 countries · 48 shipments · $112K · 23 Indian suppliers · 26 buyers
SHIPMENTS
48
USD
$112K
COUNTRIES
16
SUPPLIERS
23
BUYERS
26
HHI
5,148
concentrated
Top 16 destination countries in Asia
1
Vietnam (48.4%)
$54K
2
Malaysia (18.4%)
$21K
3
Lebanon (13.6%)
$15K
4
Kazakhstan (7.6%)
$9K
5
Afghanistan (4.8%)
$5K
6
Singapore (2.4%)
$3K
7
Nepal (1.9%)
$2K
8
Laos (1.3%)
$1K
9
United Arab Emirates (0.6%)
$658.71
10
Cambodia (0.4%)
$464.79
11
Iraq (0.4%)
$452.71
12
Maldives (0.1%)
$65.13
13
Yemen (0.0%)
$46.05
14
Philippines (0.0%)
$37.61
15
Turkey (0.0%)
$21.61
16
Sri Lanka (0.0%)
$1.08
Top 23 Indian suppliers into Asia
1
RELIANCE LIFE SCIENCES PVT LTD
$79K
2
GLOBELA PHARMA PVT LTD
$13K
3
KWALITY PHARMACEUTICALS LTD
$5K
4
INNOMEDIX PHARMA PVT LTD
$5K
5
AVALOR HEALTH CARE PVT LTD
$4K
6
RMPL PHARMA LLP
$2K
7
LEOWIN HEALTHCARE LLP
$1K
8
OCEAN PHARMACEUTICAL
$518.67
9
VANDAN HEALTHCARE
$464.79
10
RV LIFESCIENCES LTD
$405.37
11
KASO PHARMACEUTICALS
$371.18
12
PHARMA CHOICE LLP
$340.85
13
VATS INDUSTRIES PVT LTD
$273.04
14
KERK
$245.46
15
BETA DRUGS LTD
$207.04
16
RELICURE HEALTHCARE
$179.67
17
SEATRACK INTERNATIONAL TRADEX PVT LTD
$84.99
18
MC PHARMA DISTRIBUTORS
$65.13
19
IASO PHARMACEUTICALS PVT LTD
$55.05
20
J.A. UNITED EXPORTS PVT LTD
$46.05
21
SARTAJ PHARMA PVT LTD
$26.10
22
AMARI TRADE ALLIANCE LLP
$18.85
23
VAMA LIFECARE PVT LTD
$1.08
Top 24 Asia importers
1
DELTA IMPORT - EXPORT MEDICAL CO.,L · Vietnam
$54K
2
SCHMIDT BIOMEDTECH SDN BHD · Malaysia
$10K
3
TRUST ANESTHETIC LTD · Afghanistan
$5K
4
KAZBIOTECH LLP · Kazakhstan
$5K
5
TOO AVCARE LTD · Kazakhstan
$4K
6
PHARMACHEM PVT LTD · Nepal
$2K
7
WELLCHEM PHARMACEUTICALS PTE LTD · Singapore
$1K
8
ANSYNC GLOBAL FZCO · United Arab Emirates
$518.67
9
DELTA IMPORT-EXPORT MEDICAL CO., LT · Vietnam
$405.37
10
MR VONMUNA · Laos
$371.18
11
RADEEP SERVICES · Singapore
$340.85
12
MUBARAK HASHIMI LTD · Afghanistan
$245.46
13
ASBAR ALMOSTQBAL · Iraq
$177.68
14
SIJAL PHARMA PVT LTD · Nepal
$169.43
15
ATLAS TRADING COMPANY · Iraq
$91.01
16
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$84.99
17
STATE TRADING ORGANIZATION PLC · Maldives
$65.13
18
EMIRATES POST COMPANY · United Arab Emirates
$55.05
19
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$46.05
20
2MG INC · Philippines
$37.61
21
SARTAJ ENTERPRISES LTD · Afghanistan
$26.10
22
ABU ABDU · Turkey
$18.85
23
ZHARAWA LTD · Iraq
$2.00
24
AS PER INVOICE SRI LANKA · Sri Lanka
$1.08
Top 3 dosage forms
1
Capsule
$96K
2
Tablet
$16K
3
Unknown
$182.03
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $790.43 | $790.43 |
| Nov | 19 | $91K | $5K |
| Dec | 28 | $20K | $705.59 |
Shipment register · 48 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RELIANCE LIFE SCIENCES PVT LTD · 8 shipments · $79K | |||||||||||
| 1 | Oct 2025 | PHARMACHEM PVT LTD | Nepal | Capsule | 100 | NOS | $7.90 | $790.43 | RAXAUL | BIRGUNJ | ROAD |
| 2 | Nov 2025 | WELLCHEM PHARMACEUTICALS PTE LTD | Singapore | Capsule | 400 | NOS | $2.89 | $1K | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 3 | Nov 2025 | SCHMIDT BIOMEDTECH SDN BHD | Malaysia | Capsule | 1.0K | NOS | $10.29 | $10K | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Singapore | Capsule | 400 | NOS | $2.89 | $1K | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Malaysia | Capsule | 1.0K | NOS | $10.29 | $10K | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 6 | Nov 2025 | DELTA IMPORT - EXPORT MEDICAL CO.,L | Vietnam | Capsule | 3.0K | NOS | $17.89 | $54K | MUMBAI AIR (SAHAR) | HO CHI MINH C | AIR |
| 7 | Dec 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 20 | NOS | $20.46 | $409.23 | RAXAUL | BIRGUNJ | ROAD |
| 8 | Dec 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 100 | NOS | $7.79 | $779.21 | RAXAUL | BIRGUNJ | ROAD |
| SUPPLIER #2 — GLOBELA PHARMA PVT LTD · 1 shipments · $13K | |||||||||||
| 9 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 1.8K | NOS | $7.50 | $13K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #3 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $5K | |||||||||||
| 10 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Capsule | 60.0K | NOS | $0.084 | $5K | DELHI AIR | KABUL | AIR |
| SUPPLIER #4 — INNOMEDIX PHARMA PVT LTD · 2 shipments · $5K | |||||||||||
| 11 | Nov 2025 | KAZBIOTECH LLP | Kazakhstan | Capsule | 650 | NOS | $3.71 | $2K | DELHI AIR | ALMATY | AIR |
| 12 | Nov 2025 | KAZBIOTECH LLP | Kazakhstan | Capsule | 650 | NOS | $3.71 | $2K | DELHI AIR | ALMATY | AIR |
| SUPPLIER #5 — AVALOR HEALTH CARE PVT LTD · 1 shipments · $4K | |||||||||||
| 13 | Nov 2025 | TOO AVCARE LTD | Kazakhstan | Capsule | 475 | NOS | $7.79 | $4K | DELHI AIR | ALMATY | AIR |
| SUPPLIER #6 — RMPL PHARMA LLP · 7 shipments · $2K | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 200 | NOS | $3.90 | $779.74 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 48 | NOS | $8.99 | $431.31 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 52 | NOS | $8.99 | $467.26 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Turkey | Capsule | 60 | NOS | $0.046 | $2.76 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 16 | NOS | $0.045 | $0.719 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 2 | NOS | $0.045 | $0.090 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 12 | NOS | $0.045 | $0.540 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #7 — LEOWIN HEALTHCARE LLP · 1 shipments · $1K | |||||||||||
| 21 | Dec 2025 | UNLISTED BUYER | Laos | Capsule | 100 | NOS | $10.71 | $1K | AHMEDABAD AIR | VIENTIANE | AIR |
| SUPPLIER #8 — OCEAN PHARMACEUTICAL · 1 shipments · $518.67 | |||||||||||
| 22 | Dec 2025 | ANSYNC GLOBAL FZCO | United Arab Emirates | Capsule | 95 | NOS | $5.46 | $518.67 | AHMEDABAD AIR | SHARJAH | AIR |
| SUPPLIER #9 — VANDAN HEALTHCARE · 4 shipments · $464.79 | |||||||||||
| 23 | Nov 2025 | UNLISTED BUYER | Cambodia | Capsule | 10 | NOS | $14.48 | $144.75 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| 24 | Nov 2025 | UNLISTED BUYER | Cambodia | Capsule | 20 | NOS | $5.49 | $109.81 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| 25 | Dec 2025 | UNLISTED BUYER | Cambodia | Tablet | 20 | NOS | $6.63 | $132.67 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | Cambodia | Tablet | 20 | NOS | $3.88 | $77.56 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #10 — RV LIFESCIENCES LTD · 1 shipments · $405.37 | |||||||||||
| 27 | Dec 2025 | DELTA IMPORT-EXPORT MEDICAL CO., LT | Vietnam | Capsule | 2.0K | NOS | $0.203 | $405.37 | MUMBAI AIR (SAHAR) | HANOI - NOIBAI | SEA |
| SUPPLIER #11 — KASO PHARMACEUTICALS · 1 shipments · $371.18 | |||||||||||
| 28 | Dec 2025 | MR VONMUNA | Laos | Tablet | 100 | NOS | $3.71 | $371.18 | DELHI AIR | VIENTIANE | AIR |
| SUPPLIER #12 — PHARMA CHOICE LLP · 1 shipments · $340.85 | |||||||||||
| 29 | Nov 2025 | RADEEP SERVICES | Singapore | Tablet | 50 | NOS | $6.82 | $340.85 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #13 — VATS INDUSTRIES PVT LTD · 3 shipments · $273.04 | |||||||||||
| 30 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | 20 | NOS | $4.55 | $91.01 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| 31 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 20 | NOS | $4.55 | $91.01 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 32 | Nov 2025 | UNKNOWN BUYER | Iraq | 20 | NOS | $4.55 | $91.01 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| SUPPLIER #14 — KERK · 1 shipments · $245.46 | |||||||||||
| 33 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Capsule | 180 | NOS | $1.36 | $245.46 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #15 — BETA DRUGS LTD · 2 shipments · $207.04 | |||||||||||
| 34 | Dec 2025 | 2MG INC | Philippines | Capsule | 250 | NOS | $0.150 | $37.61 | DELHI AIR | MANILA | SEA |
| 35 | Dec 2025 | SIJAL PHARMA PVT LTD | Nepal | Capsule | 50 | NOS | $3.39 | $169.43 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #16 — RELICURE HEALTHCARE · 2 shipments · $179.67 | |||||||||||
| 36 | Dec 2025 | ASBAR ALMOSTQBAL | Iraq | Capsule | 40 | NOS | $4.44 | $177.68 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 37 | Dec 2025 | ZHARAWA LTD | Iraq | Capsule | 40 | NOS | $0.050 | $2.00 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #17 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $84.99 | |||||||||||
| 38 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Capsule | 20 | NOS | $4.25 | $84.99 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #18 — MC PHARMA DISTRIBUTORS · 1 shipments · $65.13 | |||||||||||
| 39 | Nov 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 30 | PCS | $2.17 | $65.13 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #19 — IASO PHARMACEUTICALS PVT LTD · 3 shipments · $55.05 | |||||||||||
| 40 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 2 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 41 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 2 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 42 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 2 | PCS | $27.52 | $55.05 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #20 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $46.05 | |||||||||||
| 43 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Capsule | 5 | NOS | $9.21 | $46.05 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #21 — SARTAJ PHARMA PVT LTD · 1 shipments · $26.10 | |||||||||||
| 44 | Dec 2025 | SARTAJ ENTERPRISES LTD | Afghanistan | Capsule | 1.2K | NOS | $0.022 | $26.10 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #22 — AMARI TRADE ALLIANCE LLP · 1 shipments · $18.85 | |||||||||||
| 45 | Dec 2025 | ABU ABDU | Turkey | Capsule | 500 | NOS | $0.038 | $18.85 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #23 — VAMA LIFECARE PVT LTD · 3 shipments · $1.08 | |||||||||||
| 46 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Capsule | 5 | NOS | $0.113 | $0.565 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 47 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Capsule | 8 | NOS | $0.051 | $0.411 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 48 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Capsule | 2 | NOS | $0.051 | $0.103 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
5 countries · 24 shipments · $341K · 5 Indian suppliers · 5 buyers
SHIPMENTS
24
USD
$341K
COUNTRIES
5
SUPPLIERS
5
BUYERS
5
HHI
7,799
concentrated
Top 5 destination countries in Europe
1
Belgium (87.5%)
$298K
2
Hungary (12.3%)
$42K
3
Poland (0.2%)
$598.98
4
United Kingdom (0.1%)
$268.20
5
Lithuania (0.0%)
$102.39
Top 5 Indian suppliers into Europe
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$298K
2
JODAS EXPOIM PVT LTD
$42K
3
HEET HEALTHCARE PVT LTD
$598.98
4
NIVIRA EXPORTS
$268.20
5
SPECIALITY MEDICINES LTD
$102.39
Top 4 Europe importers
1
YUSEN LOGISTICS BENELUX BELGIUMKEET · Belgium
$168K
2
YUSEN LOGISTICS BENELUX BELGIUM · Belgium
$131K
3
PHARMACENTER HUNGARY LTD · Hungary
$42K
4
TO THE PURCHASE DEPT · United Kingdom
$268.20
Top 3 dosage forms
1
Capsule
$341K
2
Unknown
$598.98
3
Other
$102.39
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $168K | $24K |
| Nov | 8 | $98K | $12K |
| Dec | 9 | $75K | $8K |
Shipment register · 24 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 15 shipments · $298K | |||||||||||
| 1 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 977 | NOS | $56.63 | $55K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 2 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 8.4K | NOS | $1.53 | $13K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 3 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 3.4K | NOS | $6.10 | $21K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 4 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 1.1K | NOS | $7.69 | $8K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 5 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 4.5K | NOS | $3.52 | $16K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 6 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 1.3K | NOS | $1.34 | $2K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 7 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | Capsule | 4.0K | NOS | $13.14 | $53K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 8 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 1.2K | NOS | $10.28 | $13K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 9 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 8.8K | NOS | $3.05 | $27K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 10 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 3.5K | NOS | $1.95 | $7K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 11 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 9.0K | NOS | $3.06 | $28K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 12 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 8.9K | NOS | $2.63 | $24K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 13 | Dec 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 7.4K | NOS | $3.34 | $25K | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| 14 | Dec 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 6.6K | NOS | $1.28 | $8K | DELHI AIR | BRUSSELS | AIR |
| 15 | Dec 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 1.4K | NOS | $0.012 | $16.22 | NHAVA SHEVA SEA (JNPT) | Antwerpen | SEA |
| SUPPLIER #2 — JODAS EXPOIM PVT LTD · 4 shipments · $42K | |||||||||||
| 16 | Dec 2025 | PHARMACENTER HUNGARY LTD | Hungary | Capsule | 5.2K | NOS | $2.14 | $11K | MUMBAI AIR (SAHAR) | BUDAPEST, | AIR |
| 17 | Dec 2025 | PHARMACENTER HUNGARY LTD | Hungary | Capsule | 5.2K | NOS | $2.88 | $15K | MUMBAI AIR (SAHAR) | BUDAPEST, | AIR |
| 18 | Dec 2025 | PHARMACENTER HUNGARY LTD | Hungary | Capsule | 1.5K | NOS | $3.37 | $5K | MUMBAI AIR (SAHAR) | BUDAPEST, | AIR |
| 19 | Dec 2025 | PHARMACENTER HUNGARY LTD | Hungary | Capsule | 2.5K | NOS | $4.31 | $11K | MUMBAI AIR (SAHAR) | BUDAPEST, | AIR |
| SUPPLIER #3 — HEET HEALTHCARE PVT LTD · 3 shipments · $598.98 | |||||||||||
| 20 | Nov 2025 | UNLISTED BUYER | Poland | 10 | NOS | $19.97 | $199.66 | AHMEDABAD AIR | WARSAW | AIR | |
| 21 | Nov 2025 | UNLISTED BUYER | Poland | 10 | NOS | $19.97 | $199.66 | AHMEDABAD AIR | WARSAW | AIR | |
| 22 | Nov 2025 | UNLISTED BUYER | Poland | 10 | NOS | $19.97 | $199.66 | AHMEDABAD AIR | WARSAW | AIR | |
| SUPPLIER #4 — NIVIRA EXPORTS · 1 shipments · $268.20 | |||||||||||
| 23 | Dec 2025 | TO THE PURCHASE DEPT | United Kingdom | Capsule | 30 | NOS | $8.94 | $268.20 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| SUPPLIER #5 — SPECIALITY MEDICINES LTD · 1 shipments · $102.39 | |||||||||||
| 24 | Dec 2025 | UNLISTED BUYER | Lithuania | Other | 10 | SET | $10.24 | $102.39 | MUMBAI AIR (SAHAR) | VILNIUS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
8 countries · 24 shipments · $1.35M · 7 Indian suppliers · 9 buyers
SHIPMENTS
24
USD
$1.35M
COUNTRIES
8
SUPPLIERS
7
BUYERS
9
HHI
9,692
concentrated
Top 8 destination countries in Americas
1
Colombia (57.6%)
$779K
2
Brazil (23.9%)
$324K
3
Canada (17.0%)
$229K
4
Paraguay (0.8%)
$11K
5
Peru (0.4%)
$5K
6
Chile (0.3%)
$4K
7
Mexico (0.1%)
$680.59
8
El Salvador (0.0%)
$304.78
Top 7 Indian suppliers into Americas
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$1.33M
2
RELIANCE LIFE SCIENCES PVT LTD
$11K
3
CSP LIFESCIENCES PVT LTD
$5K
4
VITALITYMED
$4K
5
MEDINEX HEALTHCARE
$529.56
6
PHARMEDA HEALTHCARE PVT LTD
$304.78
7
VAMA HEALTH WORLD LLP
$151.03
Top 7 Americas importers
1
LABORATORIOS LA SANTE S.A · Colombia
$389K
2
SUN FARMACEUTICA DO BRASIL LTDA · Brazil
$277K
3
M/S.SUN PHARMA CANADA INC · Canada
$229K
4
BIOTENG S.A · Paraguay
$11K
5
FARMADONIC LTD · Chile
$4K
6
JAMP PHARMA CORP · Canada
$382.69
7
AS PER INVOICE MEXICO · Mexico
$151.03
Top 2 dosage forms
1
Capsule
$1.34M
2
Tablet
$15K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $229K | $115K |
| Nov | 11 | $1.11M | $101K |
| Dec | 11 | $17K | $2K |
Shipment register · 24 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 10 shipments · $1.33M | |||||||||||
| 1 | Oct 2025 | M/S.SUN PHARMA CANADA INC | Canada | Capsule | 1.4K | PCS | $55.58 | $77K | DHANNAD ICD | Newark | ICD |
| 2 | Oct 2025 | M/S.SUN PHARMA CANADA INC | Canada | Capsule | 1.1K | PCS | $143.62 | $152K | DHANNAD ICD | Newark | ICD |
| 3 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Capsule | 44.5K | NOS | $1.12 | $50K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| 4 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Capsule | 29.6K | NOS | $3.01 | $89K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| 5 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Capsule | 44.5K | NOS | $1.05 | $47K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| 6 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Capsule | 8.9K | NOS | $5.23 | $47K | DELHI AIR | R JANIERO , RJ | AIR |
| 7 | Nov 2025 | LABORATORIOS LA SANTE S.A | Colombia | Capsule | 9.2K | NOS | $42.43 | $389K | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | Brazil | Capsule | 8.9K | NOS | $5.23 | $47K | DELHI AIR | R JANIERO , RJ | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Colombia | Capsule | 9.2K | NOS | $42.43 | $389K | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| 10 | Nov 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Capsule | 1.2K | NOS | $37.86 | $45K | DELHI AIR | R JANIERO , RJ | AIR |
| SUPPLIER #2 — RELIANCE LIFE SCIENCES PVT LTD · 3 shipments · $11K | |||||||||||
| 11 | Dec 2025 | BIOTENG S.A | Paraguay | Tablet | 2.9K | NOS | $3.75 | $11K | MUMBAI AIR (SAHAR) | ASUNCION | AIR |
| 12 | Dec 2025 | JAMP PHARMA CORP | Canada | Tablet | 2.0K | NOS | $0.033 | $66.06 | MUMBAI AIR (SAHAR) | Montreal-Doraval Apt | AIR |
| 13 | Dec 2025 | JAMP PHARMA CORP | Canada | Tablet | 2.0K | NOS | $0.158 | $316.63 | MUMBAI AIR (SAHAR) | Montreal-Doraval Apt | AIR |
| SUPPLIER #3 — CSP LIFESCIENCES PVT LTD · 1 shipments · $5K | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Peru | Capsule | 5.0K | NOS | $1.06 | $5K | DELHI AIR | LIMA - | AIR |
| SUPPLIER #4 — VITALITYMED · 2 shipments · $4K | |||||||||||
| 15 | Nov 2025 | FARMADONIC LTD | Chile | Tablet | 1 | NOS | $2K | $2K | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| 16 | Nov 2025 | FARMADONIC LTD | Chile | Tablet | 1 | NOS | $2K | $2K | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #5 — MEDINEX HEALTHCARE · 5 shipments · $529.56 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 20 | NOS | $11.77 | $235.36 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 10 | NOS | $11.77 | $117.68 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 5 | NOS | $11.77 | $58.84 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 10 | NOS | $3.92 | $39.23 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 20 | NOS | $3.92 | $78.45 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #6 — PHARMEDA HEALTHCARE PVT LTD · 1 shipments · $304.78 | |||||||||||
| 22 | Nov 2025 | UNKNOWN BUYER | El Salvador | Capsule | 50 | PCS | $6.10 | $304.78 | DELHI AIR | SALVADOR | AIR |
| SUPPLIER #7 — VAMA HEALTH WORLD LLP · 2 shipments · $151.03 | |||||||||||
| 23 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Capsule | 20 | NOS | $5.10 | $102.05 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 24 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Capsule | 20 | NOS | $2.45 | $48.98 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 40 Indian temozolomide exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped temozolomide in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 25 | $1.63M | Capsule | Europe, Americas |
| 2 | RELIANCE LIFE SCIENCES PVT LTD | NAVI MUMBAI MAHARASHTRA | 11 | $90K | Capsule, Tablet | Asia, Americas |
| 3 | JODAS EXPOIM PVT LTD | SIDDIPET DIST | 4 | $42K | Capsule | Europe |
| 4 | GLOBELA PHARMA PVT LTD | SURAT | 1 | $13K | Tablet | Asia |
| 5 | CSP LIFESCIENCES PVT LTD | Ahmedabad | 1 | $5K | Capsule | Americas |
| 6 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 1 | $5K | Capsule | Asia |
| 7 | INNOMEDIX PHARMA PVT LTD | JAIPUR | 2 | $5K | Capsule | Asia |
| 8 | AVALOR HEALTH CARE PVT LTD | NOIDA | 1 | $4K | Capsule | Asia |
| 9 | VITALITYMED | Rajkot | 2 | $4K | Tablet | Americas |
| 10 | BAKER & DAVIS PVT LTD | MUMBAI | 6 | $3K | Capsule | Africa |
| 11 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 5 | $2K | Capsule | Africa |
| 12 | RMPL PHARMA LLP | MUMBAI | 7 | $2K | Capsule | Asia |
| 13 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 7 | $2K | Capsule | Africa, Europe |
| 14 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 1 | $1K | Capsule | Asia |
| 15 | MATU INTERNATIONAL PVT LTD | NEW DELHI | 2 | $979.68 | Capsule | Africa |
| 16 | MEDINEX HEALTHCARE | Mumbai | 5 | $529.56 | Tablet | Americas |
| 17 | OCEAN PHARMACEUTICAL | VADODARA | 1 | $518.67 | Capsule | Asia |
| 18 | VANDAN HEALTHCARE | AHMEDABAD | 4 | $464.79 | Capsule, Tablet | Asia |
| 19 | RV LIFESCIENCES LTD | AURANGABAD | 1 | $405.37 | Capsule | Asia |
| 20 | KASO PHARMACEUTICALS | NEW DELHI | 1 | $371.18 | Tablet | Asia |
| 21 | PHARMA CHOICE LLP | MULUND EAST | 1 | $340.85 | Tablet | Asia |
| 22 | PHARMEDA HEALTHCARE PVT LTD | NEW DELHI | 1 | $304.78 | Capsule | Americas |
| 23 | SANSKRUTI PHARMA | SURAT | 3 | $277.70 | Tablet | Africa |
| 24 | VATS INDUSTRIES PVT LTD | NEW DELHI | 3 | $273.04 | Tablet | Asia |
| 25 | NIVIRA EXPORTS | MUMBAI | 1 | $268.20 | Capsule | Europe |
| 26 | AMARI TRADE ALLIANCE LLP | MUMBAI | 3 | $255.91 | Capsule | Africa, Asia |
| 27 | KERK | DELHI | 1 | $245.46 | Capsule | Asia |
| 28 | BETA DRUGS LTD | BADDI | 2 | $207.04 | Capsule | Asia |
| 29 | SEVATTO PHARMACEUTICALS PVT LTD | VADODARA | 1 | $205.08 | Capsule | Africa |
| 30 | KLV HEALTHCARE PVT LTD | DAHISAR | 1 | $199.00 | Capsule | Africa |
| 31 | RELICURE HEALTHCARE | DELHI | 2 | $179.67 | Capsule | Asia |
| 32 | VAMA HEALTH WORLD LLP | Mumbai | 2 | $151.03 | Capsule | Americas |
| 33 | SPECIALITY MEDICINES LTD | MUMBAI | 1 | $102.39 | Other | Europe |
| 34 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $84.99 | Capsule | Asia |
| 35 | J.A. UNITED EXPORTS PVT LTD | VASHI | 3 | $66.75 | Capsule | Africa, Asia |
| 36 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $65.13 | Capsule | Asia |
| 37 | IASO PHARMACEUTICALS PVT LTD | NEW DELHI | 3 | $55.05 | Capsule | Asia |
| 38 | SARTAJ PHARMA PVT LTD | CHANDNI CHOWK | 1 | $26.10 | Capsule | Asia |
| 39 | VAMA LIFECARE PVT LTD | MUMBAI | 3 | $1.08 | Capsule | Asia |
| 40 | BRUCK PHARMA PVT LTD | NANI | 2 | $0.382 | Capsule | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 37 global temozolomide importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian temozolomide in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | LABORATORIOS LA SANTE S.A | Colombia | 1 | $389K | SUN PHARMACEUTICAL I… | Capsule |
| 2 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | 5 | $277K | SUN PHARMACEUTICAL I… | Capsule |
| 3 | M/S.SUN PHARMA CANADA INC | Canada | 2 | $229K | SUN PHARMACEUTICAL I… | Capsule |
| 4 | YUSEN LOGISTICS BENELUX BELGIUMKEET | Belgium | 7 | $168K | SUN PHARMACEUTICAL I… | Capsule |
| 5 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | 8 | $131K | SUN PHARMACEUTICAL I… | Capsule |
| 6 | DELTA IMPORT - EXPORT MEDICAL CO.,L | Vietnam | 1 | $54K | RELIANCE LIFE SCIENC… | Capsule |
| 7 | PHARMACENTER HUNGARY LTD | Hungary | 4 | $42K | JODAS EXPOIM PVT LTD | Capsule |
| 8 | BIOTENG S.A | Paraguay | 1 | $11K | RELIANCE LIFE SCIENC… | Tablet |
| 9 | SCHMIDT BIOMEDTECH SDN BHD | Malaysia | 1 | $10K | RELIANCE LIFE SCIENC… | Capsule |
| 10 | TRUST ANESTHETIC LTD | Afghanistan | 1 | $5K | KWALITY PHARMACEUTIC… | Capsule |
| 11 | KAZBIOTECH LLP | Kazakhstan | 2 | $5K | INNOMEDIX PHARMA PVT… | Capsule |
| 12 | TOO AVCARE LTD | Kazakhstan | 1 | $4K | AVALOR HEALTH CARE P… | Capsule |
| 13 | FARMADONIC LTD | Chile | 2 | $4K | VITALITYMED | Tablet |
| 14 | PHARMACHEM PVT LTD | Nepal | 3 | $2K | RELIANCE LIFE SCIENC… | Capsule, Tablet |
| 15 | FREIGHTER MADE LOGISTICS LTD | Ghana | 3 | $1K | BAKER & DAVIS PVT LTD | Capsule |
| 16 | WELLCHEM PHARMACEUTICALS PTE LTD | Singapore | 1 | $1K | RELIANCE LIFE SCIENC… | Capsule |
| 17 | ANSYNC GLOBAL FZCO | United Arab Emirates | 1 | $518.67 | OCEAN PHARMACEUTICAL | Capsule |
| 18 | DELTA IMPORT-EXPORT MEDICAL CO., LT | Vietnam | 1 | $405.37 | RV LIFESCIENCES LTD | Capsule |
| 19 | JAMP PHARMA CORP | Canada | 2 | $382.69 | RELIANCE LIFE SCIENC… | Tablet |
| 20 | MR VONMUNA | Laos | 1 | $371.18 | KASO PHARMACEUTICALS | Tablet |
| 21 | RADEEP SERVICES | Singapore | 1 | $340.85 | PHARMA CHOICE LLP | Tablet |
| 22 | TO THE PURCHASE DEPT | United Kingdom | 1 | $268.20 | NIVIRA EXPORTS | Capsule |
| 23 | MUBARAK HASHIMI LTD | Afghanistan | 1 | $245.46 | KERK | Capsule |
| 24 | ABU AHMED | Kenya | 2 | $237.06 | AMARI TRADE ALLIANCE… | Capsule |
| 25 | ASBAR ALMOSTQBAL | Iraq | 1 | $177.68 | RELICURE HEALTHCARE | Capsule |
| 26 | SIJAL PHARMA PVT LTD | Nepal | 1 | $169.43 | BETA DRUGS LTD | Capsule |
| 27 | AS PER INVOICE MEXICO | Mexico | 2 | $151.03 | VAMA HEALTH WORLD LLP | Capsule |
| 28 | ATLAS TRADING COMPANY | Iraq | 1 | $91.01 | VATS INDUSTRIES PVT … | |
| 29 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $84.99 | SEATRACK INTERNATION… | Capsule |
| 30 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | 3 | $66.75 | J.A. UNITED EXPORTS … | Capsule |
| 31 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $65.13 | MC PHARMA DISTRIBUTORS | Capsule |
| 32 | EMIRATES POST COMPANY | United Arab Emirates | 3 | $55.05 | IASO PHARMACEUTICALS… | Capsule |
| 33 | 2MG INC | Philippines | 1 | $37.61 | BETA DRUGS LTD | Capsule |
| 34 | SARTAJ ENTERPRISES LTD | Afghanistan | 1 | $26.10 | SARTAJ PHARMA PVT LTD | Capsule |
| 35 | ABU ABDU | Turkey | 1 | $18.85 | AMARI TRADE ALLIANCE… | Capsule |
| 36 | ZHARAWA LTD | Iraq | 1 | $2.00 | RELICURE HEALTHCARE | Capsule |
| 37 | AS PER INVOICE SRI LANKA | Sri Lanka | 3 | $1.08 | VAMA LIFECARE PVT LTD | Capsule |
This report covers 124 2025-Q4 Temozolomide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/temozolomide
Talk to our trade analyst
Need a custom temozolomide report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/temozolomide
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Temozolomide product page
Live data, supplier directory, price trends, and trade route analysis